We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Five-Marker Panel Helps Diagnose Lupus

By LabMedica International staff writers
Posted on 17 Jan 2012
A five-marker panel was designed to Rule-In Systemic Lupus Erythematosus (SLE) and Rule-Out other rheumatic diseases to help establish an accurate SLE diagnosis.

Called Avise SLE, the panel includes testing of antinuclear antibodies (ANA), anti-double stranded DNA antibodies (dsDNA), anti-mutated citrullinated vimentin antibodies (Avise MCV), EC4d, and BC4d. More...
The cell-bound complements rule-in SLE because of their increased performance over soluble complements, which help to accurately and consistently diagnose SLE.

ANA, dsDNA, and AntiMCV are measured using enzyme-linked immunosorbent assay (ELISA) whereas EC4d and BC4d are measured using flow cytometry. A negative result for ANA helps rule-out the possibility of SLE. A positive result for dsDNA rules-in SLE. AVISE MCV rules-out Rheumatoid Arthritis.

Exagen Diagnostics, Inc. (Albuquerque, NM, USA), a specialty focused molecular diagnostics laboratory that discovers, develops and markets proprietary tests for rheumatologists and gastroenterologists, launched the Avise SLE, which aids in the diagnosis of lupus (Systemic Lupus Erythematosus).

The serological and flow cytometric tests are performed using a standard blood specimen, and shipped to Exagen's specialized Clinical Laboratory Improvement Amendments (CLIA) registered, College of American Pathologists (CAP) certified laboratory for processing. The company provides kits, pays shipping costs, and returns test results in 7 business days

Related Links:

Exagen Diagnostics, Inc.




Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Aspiration System
VACUSAFE
Pipette Calibration System
Artel PCS®
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers developed three mathematical biomarkers from routine PSA blood tests that may help predict early prostate cancer treatment outcomes and personalize adaptive therapy (Image Credit: Adobe Stock)

Mathematical Biomarkers Use Routine Blood Tests to Guide Adaptive Prostate Cancer Therapy

Personalizing systemic therapy for prostate cancer remains challenging because tumors can evolve under treatment pressure, driving resistance and early relapse. Continuous high-dose regimens may initially... Read more

Molecular Diagnostics

view channel
Image: The duet mosaic family comprises duet +modC mosaic and duet 6-base mosaic, two cfDNA-optimized multiomic sequencing workflows for liquid biopsy and translational research. (Photo courtesy of bimodal)

New Liquid Biopsy Workflow Maximizes Tumor Signals from Limited Blood Samples

Liquid biopsy seeks to detect tumor-derived signals from small blood samples, but circulating cell-free DNA is scarce and heterogeneous, limiting sensitivity. Combining complementary signals such as methylation,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.